Literature DB >> 19884620

Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial.

Tazeen H Jafar1, Juanita Hatcher, Neil Poulter, Muhammad Islam, Shiraz Hashmi, Zeeshan Qadri, Rasool Bux, Ayesha Khan, Fahim H Jafary, Aamir Hameed, Ata Khan, Salma H Badruddin, Nish Chaturvedi.   

Abstract

BACKGROUND: Despite convincing evidence that lowering blood pressure decreases cardiovascular morbidity and mortality, the hypertension burden remains high and control rates are poor in developing countries.
OBJECTIVE: To assess the effectiveness of 2 community-based interventions on blood pressure in hypertensive adults.
DESIGN: Cluster randomized, 2 x 2 factorial, controlled trial. (ClinicalTrials.gov registration number: NCT00327574)
SETTING: 12 randomly selected communities in Karachi, Pakistan. PATIENTS: 1341 patients 40 years or older with hypertension (systolic blood pressure >or=140 mm Hg, diastolic blood pressure >or=90 mm Hg, or already receiving treatment). MEASUREMENTS: Reduction in systolic blood pressure from baseline to end of follow-up at 2 years. INTERVENTION: Family-based home health education (HHE) from lay health workers every 3 months and annual training of general practitioners (GPs) in hypertension management.
RESULTS: The age, sex, and baseline blood pressure-adjusted decrease in systolic blood pressure was significantly greater in the HHE and GP group (10.8 mm Hg [95% CI, 8.9 to 12.8 mm Hg]) than in the GP-only, HHE-only, or no intervention groups (5.8 mm Hg [CI, 3.9 to 7.7 mm Hg] in each; P < 0.001). The interaction between the main effects of GP training and HHE on the primary outcome approached significance (interaction P = 0.004 in intention-to-treat analysis and P = 0.044 in per-protocol analysis). LIMITATIONS: Follow-up blood pressure measurements were missing for 22% of patients. No mechanism was detected by which interventions lowered blood pressure.
CONCLUSION: Family-based HHE delivered by trained lay health workers, coupled with educating GPs on hypertension, can lead to significant blood pressure reductions among patients with hypertension in Pakistan. Both strategies in combination may be feasible for upscaling within the existing health care systems of Indo-Asian countries. PRIMARY FUNDING SOURCE: Wellcome Trust.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884620     DOI: 10.7326/0003-4819-151-9-200911030-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  76 in total

1.  Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Rasool Bux; Neil Poulter; Juanita Hatcher; Nish Chaturvedi; Shah Ebrahim; Peter Cosgrove
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  High normal levels of albuminuria and risk of hypertension in Indo-Asian population.

Authors:  Saleem Jessani; Andrew S Levey; Nish Chaturvedi; Tazeen H Jafar
Journal:  Nephrol Dial Transplant       Date:  2011-05-17       Impact factor: 5.992

3.  A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India.

Authors:  Maoyi Tian; Vamadevan S Ajay; Danzeng Dunzhu; Safraj S Hameed; Xian Li; Zhong Liu; Cong Li; Hao Chen; KaWing Cho; Ruilai Li; Xingshan Zhao; Devraj Jindal; Ishita Rawal; Mohammed K Ali; Eric D Peterson; Jiachao Ji; Ritvik Amarchand; Anand Krishnan; Nikhil Tandon; Li-Qun Xu; Yangfeng Wu; Dorairaj Prabhakaran; Lijing L Yan
Journal:  Circulation       Date:  2015-07-17       Impact factor: 29.690

4.  Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis.

Authors:  Katherine T Mills; Katherine M Obst; Wei Shen; Sandra Molina; Hui-Jie Zhang; Hua He; Lisa A Cooper; Jiang He
Journal:  Ann Intern Med       Date:  2017-12-26       Impact factor: 25.391

5.  The development and validation of the hypertension evaluation of lifestyle and management knowledge scale.

Authors:  Marilyn M Schapira; Kathlyn E Fletcher; Avery Hayes; Dan Eastwood; Leslie Patterson; Kristyn Ertl; Jeff Whittle
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-04-09       Impact factor: 3.738

6.  Strategies for BP Control in Developing Countries and Effects on Kidney Function.

Authors:  Min Jun; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

7.  Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial.

Authors:  Rajnish Joshi; Twinkle Agrawal; Farah Fathima; Thammattoor Usha; Tinku Thomas; Dominic Misquith; Shriprakash Kalantri; Natesan Chidambaram; Tony Raj; Alben Singamani; Shailendra Hegde; Denis Xavier; P J Devereaux; Prem Pais; Rajeev Gupta; Salim Yusuf
Journal:  Am Heart J       Date:  2019-06-19       Impact factor: 4.749

8.  Health Education and General Practitioner Training in Hypertension Management: Long-Term Effects on Kidney Function.

Authors:  Tazeen H Jafar; John C Allen; Imtiaz Jehan; Aamir Hameed; Seyed Ehsan Saffari; Shah Ebrahim; Neil Poulter; Nish Chaturvedi
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

9.  Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Juanita Hatcher; Shiraz Hashmi; Rasool Bux; Ayesha Khan; Neil Poulter; Salma Badruddin; Nish Chaturvedi
Journal:  BMJ       Date:  2010-06-07

Review 10.  Challenges and opportunities for implementation of interventions to prevent and control CVD in low-resource settings: a report from CESCAS in Argentina.

Authors:  Adolfo L Rubinstein; Vilma E Irazola; Rosana Poggio; Pablo Gulayin; Analía Nejamis; Andrea Beratarrechea
Journal:  Glob Heart       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.